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Abstract. Several scientific evidences show that oxidative stress is associated with the origin, progression and severity of
chronic noncommunicable diseases. Due to the longer duration of life, sarcopenia, osteopenia, osteoporosis and cachexia are
considered emerging syndromes for dogs and cats. The objective was to investigate the impact of a supplementation with
resveratrol and -tocopherol (JUVENIA®) on the harmful effects of oxidative stress in adult dogs. The study was able to
demonstrate this supplementation was able to positively modulate creatine phosphokinase and alkaline phosphatase, which
are considered useful biomarkers for sarcopenia, bone formation and speed in bone remodeling. As a result of the longer
life of domestic animals and, in particular dogs, the use of food supplements with antioxidant activity could play a critical
role in reducing/delaying the onset of chronic-degenerative diseases. On the basis of the present study, the use of products
containing resveratrol and -tocopherol acetate seems to be a promising approach for improving the health of dogs.
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1. Introduction
The incidence of cardiovascular, metabolic, neu-
rodegenerative diseases and cancer has increased
significantly in the last ten years [1] and it has been
∗Corresponding author: Rau´l Francisco Pastor Tel:+54 9 11
4411 4806. E-mail: rpastor@fmed.uba.ar.
shown that the oxidative stress is one of the most
important risk factors in the development of these
pathologies [2, 3]. The metabolic processes depend
on the permanent contribution of energy through the
synthesis of ATP, by mitochondrial oxidative phos-
phorylation. The obtained ATP is the energy carrier
for all cellular systems, but mitochondria in the same
biological activity produce more than 95% of reactive
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oxygen species and free radicals present in the organ-
ism [4].
The chemical instability of free radicals, which
have one or two unpaired electron in its external
atomic orbital, is responsible for their strong oxida-
tive properties versus all biological molecules, such
as DNA, RNA, proteins, carbohydrates and structural
lipids, representing the starting point for most chronic
diseases [5]. During the evolution of the species, bio-
logical systems developed a battery of enzymatic and
non-enzymatic antioxidant tools in order to coun-
teract the dangerous effects of free radicals. This
evolutionary adaptation is not always enough to pro-
tect the biological molecules, since the redox balance
can shift towards oxidative stress [6].
It is kown that the bone mass and ability to repair
fractures in humans decreases after 30 years of age
[7]. These parameters are inversely associated with
the oxidative stress in both animals and humans [8, 9].
The incidence of non-infectious diseases is
increasing also in pets; among them, sarcopenia,
osteopenia and cachexia are considered emerging
important syndromes for dogs and cats [10, 11, 12].
Several authors suggested biological markers for
sarcopenia in dogs; among others, creatine phosphok-
inase and aspartate aminotransferase were suggested
by Tvarijonaviciute, [13]. Sarcopenia is the decline
of muscle function, which is frequently observed in
elderly both in humans and animals. Sarcopenia is the
results of different and interacting biological mecha-
nisms.
The International European Working Group on
Sarcopenia defined sarcopenia as a progressive and
widespread skeletal muscle disorder, which is asso-
ciated with a higher probability of morbidity such
as falls, fractures, physical disability and mortality
[14]. In humans after 30 years of age, strength and
skeletal muscle mass gradually decrease every year
by approximately 1 to 2% [15].
Some authors [16, 17] described very clearly how
oxidative stress and chronic inflammation could con-
tribute to sarcopenia; in fact, some pathways can
be activated or inactivated during oxidative stress
and inflammation. One of the critical steps of the
suggested pathway is the increased production of
damaged (oxidized) molecules, such as oxidized
DNA, proteins and lipids. The oxidative processes
that contribute to sarcopenia reduce satellite cell
(myogenic stem cell) number and function. Satel-
lite cell’s function is affected by oxidative stress,
which is elevated in aged muscles. Nutritional inter-
vention could be a relatively new strategy to improve
the satellite cell environment and systemic factors,
with the objective to optimize satellite cell function
in aging muscles [18]. there Several molecules have
been proposed as biomarkers for oxidative stress. For
their easy quantification, some of them seem par-
ticularly interesting to evaluate this state in dogs:
alkaline phosphatase for the speed of bone remodel-
ing [19] and 8-hydroxy-deoxy-guanosine (8(OH)dG)
as a marker of DNA damage [20, 21].
On these bases, the aim of this study was the evalu-
ation of the possible protective effects of a nutritional
intervention on oxidative stress and, consequently,
on the incidence of sarcopenia. Among the possible
dietetic solutions, a product containing resveratrol
and -tocopherol acetate was selected for the sup-
plementation, thanks to its known strong activity as
an antioxidant, [22], [30].
2. Materials and methods
2.1. Animals
Dogs included in this study were 22; they were
medium-sized adults (5.4 ± 1.4 years old), including
10 males and 12 females, castrated and wormed; their
weight was 19.4 ± 4.4 kg (average ± standard devia-
tion). Animals were free from diseases as established
by clinical examination and biochemical assays. The
dogs of this study were identified with photographic
and descriptive cards also supported by microchips
compatible with all ISO standards DATAMARS
brand. The microchips were placed subcutaneously
in the area of the cross (at the beginning of the chest
or the end of the neck). Dogs were maintained in
the same hygienic conditions and diet with or with-
out addition of the food supplement object of the
study. No other medication or food supplement was
allowed. At the day 0 of the study (D0) a baseline clin-
ical examination was performed; a sample of venous
blood was withdrawn for biochemical assays. Dur-
ing the following 45 days, dogs received twice a
day the supplement, whose composition is reported
in Table 1. Dogs received a dose/meal of 5 g of
JUVENIA® DOGS (Microsules Argentina SA Labo-
ratory; US patent required: 62659885), containing 30
mg of resveratrol and 20 UI of -tocopherol acetate;
the latter corresponds to 4% of the recommended
daily dose of Vitamin E for middle-sized dogs At the
end of the treatment period (day 45, D45), new clin-
ical examinations and analysis of venous blood were
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Table 1
Composition of the dietary supplement JUVENIA ® DOGS
Compound Composition
%
Quantity (mg)
packet 5g
Hydrolyzed bird liver 54,15 2706
Resveratrol 0.60 30
Vitamin E as acetate DL
 tocopherol 50%
0.80 40 Equivalent
to 20 UI
Chicken fat 38,36 1920
Water 5,4 270
Tween 80 0,56 28
Nipagin sodium 0,108 5,4
Nipasol sodium 0,028 1,4
Composition of dietary supplement based on JUVENIA® DOGS.
In the first column is shown, the composition in active principles;
in the second column it is shown, in percentages; The third column
shows, the amounts per dose/meal administered to each dog.
performed. From the day 45 to day 90 (D45–D90), all
dogs maintained the previous general conditions, but
the diet did not include the supplementation. At D90,
new examinations and collection of venous blood
samples were performed.
2.2. Methods
2.2.1. Measurement of DNA/RNA oxidative
damage
Both DNA and RNA are damaged by oxidation
during aging and in a variety of disease states. The
repair processes that are initiated to correct this dam-
age release multiple oxidized guanine species into
the blood and urine. An immunoassay (DNA/RNA
Oxidative Damage kit) from Cayman Chemical
(Cayman Chemical item No.589320). was used to
quantify biomarkers of DNA/RNA oxidative damage:
all three oxidized guanine species; 8-hydroxy-2’-
deoxyguanosine from DNA, 8-hydroxyguanosine
from RNA, and 8-hydroxyguanine from either DNA
or RNA. The serum of the dogs were main-
tained at -80º C and analyzed according to the kit
instructions.
Creatine phosphokinase (CPK) was quantified
by Creatine Kinase assay on the ARCHITECT c
Systems™ and the AEROSET System (Abbot Clin-
ical Chemistry).
Total Alkaline Phosphatase (ALP) and bone
subfraction (BAP) was quantified by spectropho-
tometry (Kit ALP – AMP Biosystems).
Statistics: The statistical analysis was performed
using the Student t-test for paired samples (Prim 7.0,
GraphPad, San Diego, CA, USA). The Student t-test
was selected to evaluate a single biomarker at a time,
in 3 series of paired data (D0 vs D45, D45 vs D90
and D0 vs D90) of each dog before and after the
nutritional intervention.
3. Results and discussion
In this trial, animals were observed for two con-
secutive periods of 45 days, where the basic diet
was added or not with a food supplement con-
taining antioxidants (30 mg resveratrol and 20 UI
-tocopherol acetate). The inclusion of the same dogs
in the control and treated group minimizes the possi-
bility of bias, such as intraspecies or interindividual
variability.
As reported above, creatinine phosphokinase is
considered a good biomarker for sarcopenia in dogs.
Regarding the effects observed on alkaline phos-
phatase, our hypothesis is that the nutritional
intervention can modify the speed of bone remod-
eling, modulating the balance between the bone
formation and resorption. In the absence of liver dis-
ease or pregnancy, alkaline phosphatase is an indirect
biomarker of bone formation; since blood sampling
was performed always at the same hour, the bone
remodelling was evaluated without interference by
the circadian rhythm. Different investigations showed
that after starting a treatment with drugs to decrease
bone resorption, there is a significant decrease in both
the resorption biomarkers (between 4 to 6 weeks),
and in bone formation biomarkers (between 2 and 3
months). In a large number of cases a valley value
is reached at 2 or 3 months from the beginning of
treatment and remains constant while treatment con-
tinues. Therefore, the modifications will depend on
the therapeutic agent used and the biomarker stud-
ied. [23–24 –25]. In young subjects, a high alkaline
phosphatase value indicates that there is bone remod-
eling with predominance of formation; in adults with
oxidative or postmenopausal stress, alkaline phos-
phatase is still high, but remodeling is associated with
a net predominance of resorption [19].
From the results of statistical elaboration, it has
been shown that food supplementation with antiox-
idants (resveratrol and -tocopherol acetate) can
modulate positively these biomarkers. As shown in
Table 2, after 45 days of supplementation, there was
a statistically significant reduction of serum concen-
trations of creatin (phospho) kinase (Fig. 1) and total
alkaline phosphatase (Fig. 2).
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Table 2
Results. The values expressed are the mean ± standard deviation
Biomarker Day 0 Day 45 D 90 P P P
Day 45 vs Day 90 vs Day 90 vs
Day 0 Day 45 Day 0
Creatine (phospho) kinase (CPK) UI/L 252 ± 107.1 176.5 ± 69.4 218.4 ± 67.9 <0.01 <0.05 NS
Total Alkaline phosphatase (AP). Sub
fraction bone (BAP) was average 82%
of the AP. UI/L
99.3 ± 43.0 76.3 ± 27.3 140.7 ± 93.7 <0.05 <0.01 NS
Total Alkaline phosphatase (AP) males 87,9 ± 40.9 85,8 ± 36.5 132 ± 52.5 NS <0,05 <0,05
Total Alkaline phosphatase (AP) females 103,5 ± 46,67 74,41 ± 24,77 144,90 ± 116.87 <0,05 <0,05 NS
The concentration of the serum biomarkers of sarcopenia (Creatin phosphokinase), bone remodeling (alkaline phosphatase), and DNA
damage (8(OH)dG) evaluated at the end of each period is shown. Basal on day 0, end of day 45 (with resveratrol and -tocopherol acetate)
and end of day 90 (without resveratrol and -tocopherol acetate). It was significant in the comparison of the results of day 45 versus day 0.
Same as the results of day 90 versus day 45. The evidence is that the supplement containing resveratrol and -tocopherol acetate produced
a positive modulation of sarcopenia, remodeling bone and oxidative DNA damage.
Fig. 1. Serum Creatine phosphokinase at different times and treat-
ments. Animals were observed for two consecutive periods of 45
days, where the basic diet was added or not with a food supplement
containing antioxidants (30 mg resveratrol and 20 UI-tocopherol
acetate). Creatin phosphokinase is considered a good biomarker
for sarcopenia in dogs. After 45 days of supplementation, there
was a statistically significant reduction of serum concentrations
of creatin phosphokinase, (see Table 2). These values returned to
baseline after a further 45 days of basal diet without supplementa-
tion (control).
The changes in alkaline phosphatase values were
different in males and females: the basal values of
alkaline phosphatase were higher in females, where
the nutritional intervention influenced significantly
the rate of bone remodeling at D45. Males showed
a decrease in alkaline phosphatase concentration at
the same time, but statistical significance was not
reached. After the withdraw of the supplementation,
a significant increase in the rate of bone remodeling
was observed at Day 90 in both subgroups (Fig. 4
and Fig. 5). All the dogs were castrated and free from
liver disease, therefore the decrease observed in Total
Alkaline Phosphatase values at D45, should be due
to the decrease in the speed of bone remodeling as
a result of the antioxidant activity of the nutritional
Fig. 2. Serum Alkaline Phosphatase at different times and treat-
ments. Animals were observed for two consecutive periods of 45
days, where the basic diet was added or not with a food supplement
containing antioxidants (30 mg resveratrol and 20 UI-tocopherol
acetate). From the results of statistical elaboration, it has been
shown that food supplementation with antioxidants (resveratrol
and -tocopherol acetate) can modulate positively the alkaline
phosphatase. After 45 days of supplementation, there was a statisti-
cally significant reduction of serum concentrations of total alkaline
phosphatase. These values returned to baseline after a further 45
days of basal diet without supplementation (control). Also, in this
case the increase was statistically significant, while no difference
was observed between baseline and data at day 90, (see Table 2).
supplementation with Resveratrol and -Tocopherol.
This hypothesis was confirmed by fact that values
measured at D90, after 45 days of diet without sup-
plementation (control), returned at at baseline. Also,
in this case the increase was statistically significant,
while no difference was observed between baseline
and data at day 90 (Table 2). Although not statistically
significant, a reduction of 13% of 8-Hydroxy-deoxy-
guanosine [8(OH)dG] was also observed between
day 0 and 45 (3266.7 ± 1966 versus 2856.1 ± 1380.6
pg/mL, p = 0.4273); the high variability (standard
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Fig. 3. Serum 8(OH)dG at different times and treatments. Animals
were observed for two consecutive periods of 45 days, where the
basic diet was added or not with a food supplement containing
antioxidants (30 mg resveratrol and 20 UI -tocopherol acetate).
Although not statistically significant, a 13% reduction in the mean
of 8-hydroxy-deoxy-guanosine (8 (OH) dG) was also observed
between days 0 and 45 (see Table 2). The high variability (standard
deviation) of data was probably responsible for this result. More-
over, positive changes in DNA oxidation probably need longer
periods of treatment and are also modulated by the basal diet used.
Fig. 4. Alkaline Phosphatase in males at different times and treat-
ments. D0 vs D45 NS: D45 vs D90 < 0.05: D0 vs D90 < 0.05.
Serum alkaline phosphatase in males. After 45 days of supple-
mentation, serum concentrations of total alkaline phosphatase
decreased but did not reach statistical significance. These values
returned to the beginning after 45 additional days of basal diet with-
out supplementation (control). In this case, the increase in values
from D45 to D90 was statistically significant, whereas no differ-
ences were observed between the baseline and the data on day 90,
(see Table 2).
deviation) of data was probably responsible for this
result (Fig. 3). Moreover, oxidative processes on
DNA probably need longer periods of treatment.
Urquiaga I. et al. [26] showed that moderate
wine consumption (containing resveratrol) to both
Fig. 5. Alkaline Phosphatase in females at different times and
treatments. D0 vs D45 < 0,05: D45 vs D90 < 0,05: D0 vs D90 NS
Serum alkaline phosphatase in females. After 45 days of supple-
mentation, there was a statistically significant reduction of serum
concentrations of alkaline phosphatase These values returned to
baseline after a further 45 days of basal diet without supplemen-
tation (control). Also, in this case the increase was statistically
significant, while no difference was observed between baseline
and data at day 90, (see Table 2).
an occidental or a Mediterranean diet increases
plasma antioxidant capacity, decreases oxidative
DNA damage, and normalizes endothelial function.
The results were more significant in the group con-
suming occidental diet. The improvement of feeding
and veterinary care has allowed a considerable exten-
sion of the life span of pet animals, and of dogs
and cats. Therefore, dogs show more frequently a
decreasing ability in reacting to stress, a more fre-
quent homeostatic imbalance and an increased risk of
diseases. There is a body of scientific evidences that
nutrition influences the epigenome. This dynamic
relationship between nutrition and genes through-
out the life of an organism has been recognized as
a subfield called Nutritional Epigenomic or Nutrige-
nomics. It provides promising information to improve
health and prevent diseases [27, 28, 29].
Numerous evidences show the decrease of
oxidative stress and sarcopenia by resveratrol sup-
plementation, thanks to an increasing mitochondrial
biogenesis, an improved control of the mitochondrial
fusion/fission quality, an increase of the synthesis of
antioxidant enzymes via SIRT1, and the effects simi-
lar to that of caloric restriction [30, 31, 32, 33]. Some
studies have shown that the antioxidant effect of -
tocopherol acetate is directly correlated to a decrease
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in intracellular oxidative stress and improvement of
strength and muscle mass [34]. This research on dogs
was conducted in a biology that ages approximately 7
times faster than people [35] and supports the hypoth-
esis that sarcopenia and the increased speed of bone
remodeling, which frequently affect older dogs, can
be at least partially prevented by the supplementa-
tion with antioxidants. The present study, we believe
opens interesting questions for future research in the
field of human aging and animals that would require
longer intervention times with Resveratrol alone or
in combination with other polyphenols. In fact, the
supplementation with Resveratrol and -tocopherol
acetate caused a reduction of serum concentration
in CPK and AP, which can be associated with the
pathologies considered above in adult dogs. The
correlation between supplementation and effect was
confirmed by the second treatment period, in which
the values of the two biomarkers returned to the base-
line.
In conclusion, the present investigation has shown
that the supplementation of the diet with a formula
containing resveratrol and -tocopherol acetate can
modulate serum biomarkers, such as CPK and AP,
which are associated with sarcopenia and increased
speed of bone remodelling. Since these conditions
accelerate aging and are increasing in the dog popula-
tion due to the longer life span, the use of antioxidant
supplementation could be useful in improving the
quality of life of pets.
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